Treace Medical Concepts Inc reports results for the quarter ended in March - Earnings Summary

Treace Medical Concepts

08/05/2023 23:05

* Treace Medical Concepts Inc  TMCI.OQ  reported a quarterly
adjusted loss of 23 cents​​ per share for the quarter ended in
March. The mean expectation of six analysts for the quarter was
for a loss of 23 cents per share.
    * Revenue rose 45.3% to $42.20 million from a year ago;
analysts
expected $39.25 million. 
    * Treace Medical Concepts Inc's reported EPS for the quarter
was a
loss of 23 cents​.
    * The mean earnings estimate of analysts had fallen by
about 14.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Treace Medical Concepts Inc shares had risen by 5.1% this
quarter and gained 15.1% so far this year.
    * The company reported a quarterly loss of $13.48 million.
    * Wall Street's median 12-month price target for Treace
Medical
Concepts Inc is $30.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
8 at 10:05 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.23          -0.23          Met
 Dec. 31 2022      -0.14          -0.08          Beat
 Sep. 30 2022      -0.29          -0.22          Beat
 Jun. 30 2022      -0.20          -0.31          Missed